Alpha Tau Medical Statistics
Share Statistics
Alpha Tau Medical has 84.49M
shares outstanding. The number of shares has increased by 0.84%
in one year.
| Shares Outstanding | 84.49M |
| Shares Change (YoY) | 0.84% |
| Shares Change (QoQ) | 0.65% |
| Owned by Institutions (%) | 1.4% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 85 |
| FTD / Avg. Volume | 0.19% |
Short Selling Information
The latest short interest is 101.86K, so 0.15% of the outstanding
shares have been sold short.
| Short Interest | 101.86K |
| Short % of Shares Out | 0.15% |
| Short % of Float | 0.2% |
| Short Ratio (days to cover) | 3.65 |
Valuation Ratios
The PE ratio is -6.83 and the forward
PE ratio is -8.45.
Alpha Tau Medical's PEG ratio is
-0.96.
| PE Ratio | -6.83 |
| Forward PE | -8.45 |
| PS Ratio | 0 |
| Forward PS | 0.9 |
| PB Ratio | 3.46 |
| P/FCF Ratio | -9.84 |
| PEG Ratio | -0.96 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Alpha Tau Medical.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.4,
with a Debt / Equity ratio of 0.2.
| Current Ratio | 7.4 |
| Quick Ratio | 7.4 |
| Debt / Equity | 0.2 |
| Debt / EBITDA | -0.41 |
| Debt / FCF | -0.57 |
| Interest Coverage | -104.77 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-254,000 |
| Employee Count | 125 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 6K |
| Effective Tax Rate | -0.02% |
Stock Price Statistics
The stock price has increased by -1.77% in the
last 52 weeks. The beta is 0.93, so Alpha Tau Medical's
price volatility has been higher than the market average.
| Beta | 0.93 |
| 52-Week Price Change | -1.77% |
| 50-Day Moving Average | 2.64 |
| 200-Day Moving Average | 2.68 |
| Relative Strength Index (RSI) | 53.62 |
| Average Volume (20 Days) | 44,232 |
Income Statement
| Revenue | n/a |
| Gross Profit | -1.1M |
| Operating Income | -36.04M |
| Net Income | -31.75M |
| EBITDA | -30.3M |
| EBIT | -31.4M |
| Earnings Per Share (EPS) | -0.45 |
Full Income StatementBalance Sheet
The company has 13.72M in cash and 12.54M in
debt, giving a net cash position of 1.19M.
| Cash & Cash Equivalents | 13.72M |
| Total Debt | 12.54M |
| Net Cash | 1.19M |
| Retained Earnings | -147.51M |
| Total Assets | 86.2M |
| Working Capital | 55.55M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -19.78M
and capital expenditures -2.24M, giving a free cash flow of -22.02M.
| Operating Cash Flow | -19.78M |
| Capital Expenditures | -2.24M |
| Free Cash Flow | -22.02M |
| FCF Per Share | -0.31 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
